Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam ; volume:15 ; number:12 ; day:18 ; month:12 ; year:2024 ; pages:1-17 ; date:12.2024
Cell death & disease ; 15, Heft 12 (18.12.2024), 1-17, 12.2024
- Creator
-
Vasquez, Velmarini
Kodavati, Manohar
Mitra, Joy
Vedula, Indira
Hamilton, Dale J.
Garruto, Ralph M.
Rao, K. S.
Hegde, Muralidhar L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-024-07258-5
- URN
-
urn:nbn:de:101:1-2503010609276.976127286522
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vasquez, Velmarini
- Kodavati, Manohar
- Mitra, Joy
- Vedula, Indira
- Hamilton, Dale J.
- Garruto, Ralph M.
- Rao, K. S.
- Hegde, Muralidhar L.
- SpringerLink (Online service)
Other Objects (12)
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Current trends in basic research on Parkinson’s disease: from mitochondria, lysosome to α-synuclein
New Genes Causing Hereditary Parkinson’s Disease or Parkinsonism
ER–mitochondria signaling in Parkinson’s disease
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea
Benign tremulous Parkinsonism: a unique entity or another facet of Parkinson’s disease?
Epidemiology of Parkinsonism and Parkinson’s disease in Sub-Saharan Africa: Nigerian profile
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Current trends in basic research on Parkinson’s disease: from mitochondria, lysosome to α-synuclein
New Genes Causing Hereditary Parkinson’s Disease or Parkinsonism
ER–mitochondria signaling in Parkinson’s disease
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea
Benign tremulous Parkinsonism: a unique entity or another facet of Parkinson’s disease?
Epidemiology of Parkinsonism and Parkinson’s disease in Sub-Saharan Africa: Nigerian profile
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Current trends in basic research on Parkinson’s disease: from mitochondria, lysosome to α-synuclein
New Genes Causing Hereditary Parkinson’s Disease or Parkinsonism
ER–mitochondria signaling in Parkinson’s disease
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea
Benign tremulous Parkinsonism: a unique entity or another facet of Parkinson’s disease?